These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14577421)

  • 1. Protecting the nation's military may include the use of investigational new drugs.
    Embrey E
    Account Res; 2003; 10(2):85-90. PubMed ID: 14577421
    [No Abstract]   [Full Text] [Related]  

  • 2. A new world order for human experiments.
    Moreno JD
    Account Res; 2003; 10(1):47-56. PubMed ID: 14552300
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposal on waiver of informed consent poses major issues for research ethics.
    Maloney DM
    Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
    [No Abstract]   [Full Text] [Related]  

  • 4. Informed consent and investigational new drug abuses in the U.S. military.
    Cummings ML
    Account Res; 2002; 9(2):93-103. PubMed ID: 12625353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Justiciability--waiving for the flag: should informed consent rules apply in the context of military emergencies?
    Seftel SB
    George Washington Law Rev; 1992 Jun; 60(5):1387-435. PubMed ID: 16086522
    [No Abstract]   [Full Text] [Related]  

  • 6. A military exception to "informed consent": Doe v. Sullivan.
    Moran PJ
    St Johns Law Rev; 1993; 66(3):847-63. PubMed ID: 11652729
    [No Abstract]   [Full Text] [Related]  

  • 7. Doe v. Sullivan.
    U.S. Court of Appeals, District of Columbia Circuit
    Fed Report; 1991 Jul; 938():1370-86. PubMed ID: 11648219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA seeks public comment on informed consent rules in combat situations.
    Hastings Cent Rep; 1997; 27(5):43. PubMed ID: 11645003
    [No Abstract]   [Full Text] [Related]  

  • 9. Gulf War guinea pigs: is informed consent optional during war?
    Milner CA
    J Contemp Health Law Policy; 1996; 13(1):199-232. PubMed ID: 9068242
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed consent for human drugs and biologics; determination that informed consent is not feasible; interim rule and opportunity for public comment.
    U.S. Food and Drug Administration
    Fed Regist; 1990 Dec; 55(246):52814-7. PubMed ID: 11645686
    [No Abstract]   [Full Text] [Related]  

  • 11. Protecting soldiers from friendly fire: the consent requirement for using investigational drugs and vaccines in combat.
    Annas GJ
    Am J Law Med; 1998; 24(2-3):245-60. PubMed ID: 9702274
    [No Abstract]   [Full Text] [Related]  

  • 12. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
    Schuchardt EJ
    Columbia J Law Soc Probl; 1992; 26(1):77-115. PubMed ID: 11651647
    [No Abstract]   [Full Text] [Related]  

  • 13. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
    Schuchardt EJ
    Spec Law Dig Health Care Law; 1993 Nov; (177):9-47. PubMed ID: 10130675
    [No Abstract]   [Full Text] [Related]  

  • 15. Waivers for military use of investigational agents.
    Poikonen J; McCart GM; Veatch RM
    Am J Hosp Pharm; 1991 Jul; 48(7):1525; discussion 1525-9. PubMed ID: 1882884
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating the troops.
    Howe EG; Martin ED
    Hastings Cent Rep; 1991; 21(2):21-4; discussion 24-9. PubMed ID: 2045278
    [No Abstract]   [Full Text] [Related]  

  • 17. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 18. Accessibility to new drugs for use in military and civilian exigencies when traditional human efficacy studies are not feasible; determination under the interim rule that informed consent is not feasible for military exigencies; request for comments--FDA. Request for comments.
    Fed Regist; 1997 Jul; 62(147):40996-1001. PubMed ID: 10169831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of human subjects; new drugs for investigational use; conforming amendments; final rule.
    U.S. Food and Drug Administration
    Fed Regist; 1984 Oct; 49(212):43637-8. PubMed ID: 11645532
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioterrorism, biodefense, and biotechnology in the military: a comparative analysis of legal and ethical issues in the research, development, and use of biotechnological products on American and British soldiers.
    Melson AR
    Albany Law J Sci Technol; 2004; 14(2):E1-E44. PubMed ID: 16521317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.